title: How staging directs treatment for esophageal and lung cancer.
abstract: While staging systems may seem complicated and cumbersome at times, they are designed to stratify patients into groups by prognosis and treatment. This article reviews the staging of lung cancer and esophageal cancer, and it shows how this classification translates into different treatment plans based upon this staging.
authors.affiliation: Department of Thoracic Surgery, University of Southern California School of Medicine, Los Angeles.
authors.forename: R J
authors.initials: RJ
authors.lastname: McKenna
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D004938:Esophageal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D004947:Esophagus / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects / Q000601:surgery; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000473:pathology* / Q000528:radiation effects / Q000601:surgery; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D011879:Radiotherapy Dosage; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents